Introduction to Cochrane Methodology Workshop Lund, 20-21 November 2019
Cochrane Sweden, Cochrane Norway and Cochrane Nordic welcome you to a 2-day workshop on basic Cochrane Methodology.
Location: The workshop will be held at the University of Lund, Sweden. The exact venue details will be announced later.
Who should attend: The workshop is primarily aimed at health professionals, researchers and academics with an interest in healthcare research, but is also open for anyone to join. The level is basic and prior experience from conducting systematic reviews is not a requirement.
Objectives: The workshop will provide an introduction on practical and methodological issues of how to prepare a Cochrane systematic review of the effects of interventions. Topics will include;
How to register a Cochrane title
Research question and PICO
Structure and importance of the protocol
Search strategy
Interpretation of results and meta-analysis
Risk of bias assessment
GRADE
Challenges that evidence-based medicine is facing
Format: The workshop will use a combination of lectures, small group learning based on worked examples, and plenary discussion. Participants will also be provided with a short reading list in advance of the workshop. The workshop will be taught in English.
Participant fee: 2000 SEK (approximately 190 euros). The workshop is free for authors of Cochrane reviews (the Title has to be registered on Archie).
REGISTER HERE within 30th September 2019. In October you will receive additional information.
Contact: For more information about the course please see Contact us.
New Cochrane review on the effect of malignant melonama screening
New Cochrane review looks at evidence behind malignant melanoma screening
Authors from Cochrane Sweden and Cochrane Nordic reviewed the evidence about the effects of screening for malignant melanoma (a type of skin cancer).
They concluded that general adult population screening for malignant melanoma is not supported or refuted by evidence from well-designed trials and therefore does not fulfil accepted criteria for the implementation of a screening programme. Read the full review here in the Cochrane Library.
New Cochrane review from Swedish based authors
New Cochrane review assesses which inhaled corticosteroids and inhaled device has least impact on child growth
Authors from Sweden and Brazil review evidence on the effect of inhaled corticosteroid drugs and inhaled devices on child growth.
They found that based on the choice of drug and device, there may be an effect on the size of negative effect on child growth with persistent asthma.
However, the evidence from the review is not certain enough to help people select which inhaled corticosteroid or inhalation device to use for asthma treatment in children.
The well-established benefits of this treatment outweigh the potential risk of a relatively small suppression in growth. Read the full review here in the Cochrane Library.
